2026 NPPES data Critical Care Medicine (Internal Medicine) Physician NPI 1528018256 M.D.
Verify on CMS →

EMAD ALATASSI, M.D.

Critical Care Medicine (Internal Medicine) Physician in ROSEVILLE, Michigan. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 258 beneficiaries · Critical Care Medicine (Internal Medicine) Physician avg: 1K
Generic prescribing
42%
generic claims · 58% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.6K
68 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

EMAD ALATASSI, M.D. filed 1,514 Medicare Part D claims in 2023 as a Critical Care Medicine (Internal Medicine) Physician in ROSEVILLE, Michigan, prescribing 42% generic.

2K
Part D claims, 2023
42%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

EMAD ALATASSI, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

1,514 Top 19% higher than 81% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). This entry sits in this band. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

EMAD ALATASSI, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about EMAD ALATASSI, M.D.?

Quality data not reported

NPI registry status

Active

Issued 05/11/2006

NPI 1528018256

Primary specialty

Critical Care Medicine (Internal Medicine) Physician

Mid-sized

6,631 US NPIs in this specialty

Medicare Part D claims

1,514 42% vs specialty avg

2023 prescription claims

Specialty avg: 1,069

Specialty distribution in Michigan

How Critical Care Medicine (Internal Medicine) Physician compares to other specialties among Michigan providers

Michigan providers

Critical Care Medicine (Internal Medicine) Physician share within Michigan

1. Critical Care Medicine (Internal Medicine) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Critical Care Medicine (Internal Medicine) Physician share within Michigan

Specialty board-certification context

Estimated specialty board-certified rate — Critical Care Medicine (Internal Medicine) Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Critical Care Medicine (Internal Medicine) Physician ABMS/AOA estimate

Est. board-certified rate (Critical Care Medicine (Internal Medicine) Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Critical Care Medicine (Internal Medicine) Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

EMAD ALATASSI, M.D. is a Critical Care Medicine (Internal Medicine) Physician provider practicing in ROSEVILLE, Michigan, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1528018256. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

EMAD ALATASSI, M.D. appears in the CMS NPPES registry as a Critical Care Medicine (Internal Medicine) Physician provider holding M.D. credentials at 18263 E 10 MILE RD STE D, ROSEVILLE, MI, 48066, with a listed phone of (586) 238-2060. NPI 1528018256 was issued on 05/11/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ALATASSI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,514 prescription claims written by this provider, covering 258 Medicare beneficiaries and totaling roughly $452K in drug spend, split 58% brand-name and 42% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Critical Care Medicine (Internal Medicine) Physician is a mid-sized specialty nationwide, with 6,631 enrolled providers across 53 states and an average of 1,069 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

18263 E 10 MILE RD STE D
ROSEVILLE, MI 48066

Provider Details

NPI 1528018256
Specialty Critical Care Medicine (Internal Medicine) Physician
Credentials M.D.
Gender Male
NPI Issued 05/11/2006

Hospital and facility affiliations

Facilities where EMAD ALATASSI, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

BEAUMONT MEDICAL GROUP- SPECIALTY SERVICES
GROSSE POINTE, MI
EMAD ALATASSI MD, P.C.
ROSEVILLE, MI

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for EMAD ALATASSI, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$1.6K

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Michigan MI-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 — they are NOT specific to EMAD ALATASSI, M.D.. To verify EMAD ALATASSI, M.D.'s current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

123
Total board actions, Michigan 2023
Across 120 cases
3.00
Actions per 1,000 licensees
Michigan statewide rate
probation
Most common action type
44 cases

MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

EMAD ALATASSI, M.D. — brand share 58.0%
Specialty average (est.)

58% brand-name claims vs 42% generic, on 1,514 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,514
Total Claims
$452K
Total Drug Cost
258
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,853
Total Day Supply
51,091
Brand vs Generic
58% brand / 42% generic
Brand Drug Cost
$435K
Antibiotic Claims
81

Patient Demographics

Average Patient Age
70.7 years
Avg HCC Risk Score
1.78
Gender Split
56% female / 44% male
Age Distribution
<65: 43, 65-74: 142, 75-84: 55, 85+: 18

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
255
Albuterol Sulfate Hfa
Albuterol Sulfate
185
Anoro Ellipta
Umeclidinium Brm/Vilanterol Tr
125
Ventolin Hfa
Albuterol Sulfate
86
Breo Ellipta
Fluticasone/Vilanterol
66
Methylprednisolone
51
Azithromycin
43
Mirtazapine
42
Symbicort
Budesonide/Formoterol Fumarate
42
Fluticasone Propionate
41

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Critical Care Medicine (Internal Medicine) Physician Overview

How EMAD ALATASSI, M.D. fits within the Critical Care Medicine (Internal Medicine) Physician landscape nationally.

6,631
Critical Care Medicine (Internal Medicine) Physician Providers in US
53
States with Critical Care Medicine (Internal Medicine) Physician
1,069
Avg Claims per Provider

EMAD ALATASSI, M.D.'s 1,514 claims are above the specialty average of 1,069.

Nearby Critical Care Medicine (Internal Medicine) Physician Providers in Michigan

Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as ALATASSI.

Compare Critical Care Medicine (Internal Medicine) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is EMAD ALATASSI, M.D.'s specialty?
EMAD ALATASSI, M.D. specializes in Critical Care Medicine (Internal Medicine) Physician and practices in ROSEVILLE, Michigan. Credentials: M.D..
How much does EMAD ALATASSI, M.D. prescribe under Medicare Part D?
In 2023, EMAD ALATASSI, M.D. wrote 1,514 Medicare Part D claims totaling $452K in drug costs for 258 beneficiaries.
Where is EMAD ALATASSI, M.D. located?
EMAD ALATASSI, M.D. is located at 18263 E 10 MILE RD STE D, ROSEVILLE, MI, 48066. Phone: (586) 238-2060.
What is EMAD ALATASSI, M.D.'s NPI number?
EMAD ALATASSI, M.D.'s National Provider Identifier (NPI) is 1528018256, issued on 05/11/2006.
Does EMAD ALATASSI, M.D. prescribe more brand-name or generic drugs?
EMAD ALATASSI, M.D.'s prescribing is 58% brand-name and 42% generic drugs by claim count, with $435K in brand drug costs.
How many Critical Care Medicine (Internal Medicine) Physician providers are there in the US?
There are 6,631 Critical Care Medicine (Internal Medicine) Physician providers across 53 states in the US. The average Critical Care Medicine (Internal Medicine) Physician provider writes 1,069 Medicare Part D claims per year.
What drugs does EMAD ALATASSI, M.D. prescribe most often?
Based on 2023 Medicare Part D data, EMAD ALATASSI, M.D.'s most frequently prescribed drugs include Trelegy Ellipta, Albuterol Sulfate Hfa, Anoro Ellipta. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does EMAD ALATASSI, M.D. accept Medicare?
EMAD ALATASSI, M.D. appears in CMS Medicare data with 1,514 Part D claims and 258 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify EMAD ALATASSI, M.D.'s credentials?
EMAD ALATASSI, M.D.'s NPI is 1528018256 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology